Clinical trials
Pancreatitis clinical trials
Below are recruiting pancreatitis clinical trials, each written for real people, not researchers. We’re tracking 1,042 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06278454RecruitingPhase 1
Radioactive injection for advanced pancreatic cancer
This trial tests a new radioactive injection called NRT6008 for people with pancreatic cancer that cannot be surgically removed. It aims to see if the treatment can shrink the tumor and improve survival.
Zhengzhou, HenanAges 18–80 - NCT06322680Recruiting
Drain tubes to prevent pancreas leak after Whipple surgery
This trial is testing whether draining the main pancreatic and bile ducts during a Whipple procedure can lower the risk of a pancreatic leak. The study focuses on people with a higher chance of this complication.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07696572Recruiting
Testing a new device for EUS procedures
This trial is studying a new tool called the RIVOS™ EUS access device, which is used during a type of internal ultrasound called endoscopic ultrasound (EUS). The goal is to see how well it works for people who need this procedure.
Orlando, FloridaAges 18 years+ - NCT06477159RecruitingPhase 4
Enzyme replacement for acute pancreatitis recovery
This trial tests whether a pancreatic enzyme replacement therapy (PERT) can help people who still have digestive problems after a recent episode of acute pancreatitis. The goal is to see if it improves symptoms like stomach pain, bloating, or diarrhea.
Los Angeles, CaliforniaAges 18 years+ - NCT06553651Recruiting
Freezing tool to remove dead pancreas tissue
This trial tests a new freezing tool to remove dead tissue from the pancreas after acute pancreatitis. It might help you if you have a large, painful collection of dead tissue that needs to be cleaned out through a tube down your throat.
Boston, MassachusettsAges 18 years+ - NCT06691893RecruitingPhase 3
RELiZORB for pancreatic insufficiency in tube-fed pancreatitis
This study tests whether the RELiZORB device (which helps digest fat in tube feedings) can improve symptoms for patients with pancreatitis and pancreatic enzyme insufficiency who are in the hospital and rely on a feeding tube for most of their nutrition.
Boston, MassachusettsAges 18 years+ - NCT06698458Recruiting
DaRT radiation plus chemo for advanced pancreatic cancer
This trial tests a new type of radiation called DaRT (Alpha DaRT) combined with standard chemotherapy for people with pancreatic cancer that is locally advanced or has spread. The goal is to see if adding this radiation treatment can help shrink tumors or slow the cancer's growth.
Gilbert, ArizonaAges 18–120 - NCT06939023Recruiting
Robot vs. keyhole surgery for left-side pancreas growths
This trial compares robot-assisted surgery with standard keyhole surgery to remove growths on the left side of the pancreas. It may help doctors determine which method is safer and more effective for non-cancerous or pre-cancerous conditions.
AmsterdamAges 18 years+ - NCT07015580Recruiting
Mouth bacteria in pancreatitis types
This study looks at the bacteria in your mouth to see if they are different in chronic pancreatitis and autoimmune pancreatitis. It might help doctors understand these diseases better.
Shanghai, Shanghai, ChinaAges 18 years+ - NCT07117045Recruiting
Low-dose CT scan for pancreatic cancer screening
This study uses artificial intelligence to analyze low-dose CT scans of the abdomen to detect early signs of pancreatic cancer. It may help find cancer before symptoms appear.
Shanghai, Shanghai MunicipalityAges 50 years+ - NCT07226856RecruitingPhase 2
New combo for advanced pancreatic cancer
This trial tests a new drug (BMS-986340) plus standard chemo for people whose pancreatic cancer has spread or come back. The goal is to see if this combination works better.
Scottsdale, ArizonaAges 18 years+ - NCT07269626RecruitingPhase 2
PULSAR therapy for pancreatic cancer
This trial tests whether adding a special type of radiation therapy (PULSAR) to standard chemotherapy can help control pancreatic cancer that has not spread far. It is for people who have already completed a few rounds of chemo without their cancer growing.
Seoul, Select Province/StateAges 19 years+ - NCT07529626Recruiting
Stress and Pancreatic Cancer Disease Outcomes Study
This research study examines how chronic psychological stress (long-term worry, anxiety, or emotional burden) affects the course of pancreatic cancer and related pancreatic diseases. Understanding this connection may help doctors provide better support and treatment plans for patients.
Changsha, HunanAges 18 years+ - NCT07536841Recruiting
Testing New Criteria for Autoimmune Pancreas Inflammation
This study validates a new diagnostic tool (Odesa Criteria 2026) to help doctors accurately identify autoimmune pancreatitis—a rare condition where the body attacks the pancreas. If you're being evaluated for possible pancreas inflammation, this trial may help confirm whether you have this specific type.
OdesaAges 18 years+ - NCT07605819Recruiting
Pancreatic Cancer Screening Test Study in Japan
This study tests a new blood test called the Enzeavour Assay to screen for early signs of pancreatic cancer in people without symptoms. If the test is positive, you may need imaging tests like an ultrasound or CT scan to confirm findings.
Nagakute, Aichi-kenAges 20 years+ - NCT07651358Recruiting
Web Program to Help Pancreatic Cancer Patients Exercise and Eat Better
This study tests a personalized website program called COMPASS designed to help people with stage I-III pancreatic cancer improve their exercise and diet while receiving chemotherapy before surgery. The goal is to see if this program helps patients feel better and stay stronger during treatment.
Portland, OregonAges 18 years+ - NCT06283576Enrolling by invitation
Pancreatic cancer early detection with blood test
This trial studies a blood test to find pancreatic cancer early. It may help people who are at risk or have suspicious signs.
StockholmAges 18 years+ - NCT07157033RecruitingPhase 1/Phase 2
Testing XER-001 with radiation for advanced pancreatic cancer
This trial tests a new way to deliver a drug called amifostine (XER-001) alongside intense radiation therapy (SBRT) for people with locally advanced pancreatic cancer that can't be surgically removed. The goal is to see if it's safe and effective at protecting healthy tissue while targeting the tumor.
Duarte, CaliforniaAges 18 years+ - NCT05825066RecruitingPhase 2
Chemotherapy before surgery for advanced pancreatic cancer
This trial tests giving chemotherapy before any surgery to people with borderline resectable or locally advanced pancreatic cancer. The goal is to shrink the tumor, which may make surgery more successful and improve outcomes.
Winston-Salem, North CarolinaAges 18 years+ - NCT07543263Recruiting
AI-assisted ultrasound diagnosis for pancreatic cysts
This study uses artificial intelligence to help read endoscopic ultrasound images of pancreatic cysts. It aims to make diagnosis more accurate and could help guide treatment decisions.
Jinan, ShandongAges 18 years+ - NCT04793633Enrolling by invitation
Testing a noninvasive way to collect pancreatic cells early
This study tests LINFU™, a noninvasive method to collect pancreatic cells to help detect pancreatic cancer earlier. You may be invited if you’re at higher risk or you have concerning symptoms and planned pancreas/bile testing (like EUS or CT).
Sarasota, FloridaAges 18–90 - NCT04875325Enrolling by invitation
Monitoring for pancreatic cancer coming back after surgery
This study looks at a standardized plan for check-ups to detect pancreatic cancer returning after surgery. It may help find recurrence earlier and guide what follow-up care you might need next.
Nijmegen, GelderlandAges 18 years+ - NCT04408482Recruiting
Pancreatic stent to prevent pancreatitis after ERCP procedure
This study looks at whether placing a small tube (a pancreatic stent) during an ERCP procedure can lower the chance of getting pancreatitis afterward. If you need a difficult ERCP with bile duct access, the results may help improve prevention of post-procedure pancreatitis.
HelsinkiAges 18–100 - NCT06157671Enrolling by invitation
Testing a new method to find early pancreatic cancer in high-risk people
This study is testing a new imaging method called LINFU® to see if it can find pancreatic cancer early in people who are at higher risk but have no symptoms. If you are at elevated risk for pancreatic cancer and are already getting imaging tests, this study may help improve early detection.
New York, New YorkAges 18–90
Hear when a new Pancreatitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for pancreatitis?
- Yes. Clin2 currently lists 1,042 recruiting pancreatitis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a pancreatitis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a pancreatitis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.